Norman Fields, Gottscho Capital Management, LLC Moderna, Inc. Transaction History
Norman Fields, Gottscho Capital Management, LLC
- $268 Million
- Q1 2024
A detailed history of Norman Fields, Gottscho Capital Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Norman Fields, Gottscho Capital Management, LLC holds 5,699 shares of MRNA stock, worth $660,799. This represents 0.23% of its overall portfolio holdings.
Number of Shares
5,699
Previous 5,784
1.47%
Holding current value
$660,799
Previous $575,000
5.57%
% of portfolio
0.23%
Previous 0.23%
Shares
9 transactions
Others Institutions Holding MRNA
# of Institutions
1,038Shares Held
245MCall Options Held
12.1MPut Options Held
9.36M-
Baillie Gifford & CO44.7MShares$5.18 Billion3.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA39MShares$4.53 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY25.4MShares$2.94 Billion0.06% of portfolio
-
State Street Corp Boston, MA14.5MShares$1.68 Billion0.07% of portfolio
-
Flagship Pioneering Inc. Cambridge, MA9.67MShares$1.12 Billion67.87% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $45.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...